Bacterial Resistance in Patients Receiving Post-Intravitreal Injection Antibiotics

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Bacterial Resistance
Interventions
DRUG

Ciprofloxacin

Use of topical ciprofloxacin 4x daily for 3 days after intravitreal injection using standard aseptic techniques with Povidone-Iodine is a common practice intervention in the United States, and is thought by some to reduce the risk of post-injection endophthalmitis.

DRUG

Standard Aseptic Technique

Patients in this group will have received Povidone-Iodine Only following injections of anti-VEGF agents at least 3 times in the last 6 months.

Trial Locations (1)

92354

Loma Linda University of Health Sciences Faculty Medical Offices, Loma Linda

All Listed Sponsors
lead

Loma Linda University

OTHER

NCT02223338 - Bacterial Resistance in Patients Receiving Post-Intravitreal Injection Antibiotics | Biotech Hunter | Biotech Hunter